Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 87
Filter
1.
J Biol Regul Homeost Agents ; 30(2): 589-92, 2016.
Article in English | MEDLINE | ID: mdl-27358153

ABSTRACT

Mammary Paget’s disease (MPD) is a malignant breast tumor, which is characterized by intraepidermal infiltration from malignant glandular epithelial cells. Often it may include an underlying ductal carcinoma in situ or an invasive ductal carcinoma. Clinically it appears as an erythematous patch, moist or crusted, with or without desquamation that in some cases becomes ulcerated, causing infiltration and inversion of the nipple. We report the clinical case of a 60-year-old woman, treated in our department for psoriasis, presenting with erythema of nipple and areola with nipple erosion, ulceration and poor secretion. Suspecting Paget’s disease of the nipple, radiological exams (mammography and breast MRI) were performed. A biopsy for histological examination was carried out and confirmed the diagnosis of mammary Paget’s disease. MPD is sometimes difficult to diagnose both clinically and radiologically, therefore it is important to distinguish from other conditions: in literature MPD is reported in differential diagnosis with psoriasis given its similar clinical features, and in some cases MPD has been treated with topical and systemic steroids due to a wrong diagnosis. However, the concomitance, in the same individual, of mammary Paget’s disease and psoriasis has never been described.


Subject(s)
Breast Neoplasms/etiology , Paget's Disease, Mammary/etiology , Psoriasis/complications , Female , Humans , Middle Aged
2.
Forensic Sci Int ; 229(1-3): e1-5, 2013 Jun 10.
Article in English | MEDLINE | ID: mdl-23582265

ABSTRACT

We report the case of a 70-year-old woman found dead in her apartment in the South of Italy in February 2011. The detailed data showed that the victim was affected by familiar-type paranoid schizophrenia. This finding was confirmed by the discovery of antipsychotic and tricyclic antidepressant drugs in the house and the deposition of her psychiatric therapist. Before the autopsy, a multislice computed tomography (MSCT) scanning of the thoracic and facial maxillo-cervical area was performed that has allowed anatomical identification and diagnosis of a mechanical obstruction as the cause of death. The autopsy has showed the presence of materials obstructing the trachea totally. Histological and toxicological investigations were carried out on the victim. The toxicological investigation has shown the presence of metabolites of tricyclic antidepressants and antipsychotics in the blood and urine. The histology showed the presence of foreign-origin materials (starch fibres) inside the pulmonary alveolus. The cause of death was asphyxia due to obstruction by food-origin material. In this case the radiological data have been compared with the autopsy and toxicological and histological data. The comparison of results has shown that MSCT scanning may aid in identification of occlusion and then in determination of the cause of death. In conclusion, MSCT scanning can be proposed in the cases of suspected asphyxia, as the screening procedure of first instance to produce preliminary information useful to rapidly develop the successive autopsy performance.


Subject(s)
Airway Obstruction/diagnostic imaging , Airway Obstruction/pathology , Asphyxia/etiology , Autopsy/methods , Foreign Bodies/diagnostic imaging , Foreign Bodies/pathology , Aged , Airway Obstruction/etiology , Bread , Esophagus/pathology , Female , Humans , Jaw, Edentulous, Partially/complications , Multidetector Computed Tomography , Periodontal Diseases/complications , Trachea/pathology
3.
ScientificWorldJournal ; 2012: 943412, 2012.
Article in English | MEDLINE | ID: mdl-22919362

ABSTRACT

Inverted papilloma (IP) is a benign but locally aggressive sinonasal tumour. Aggressive surgical treatment has thus been traditionally recommended because of the risk of transformation in squamous carcinoma. CT and MRI are used to evaluate bone destruction and soft-tissue extension before surgery but may be ineffective to differentiate an inverted papilloma from squamous cell carcinoma. In recent years, F-18 Fluorodeoxyglucose positron emission tomography ((18)FDG-PET) is widely used as diffuse imaging procedure for diagnosis and followup of malignancy affecting the head and neck district. To evaluate the utility of (18)FDG-PET/CT in the diagnosis of patients with suspicious lesions for IP, twelve patients with suspicious sinonasal inverted papilloma were selected for this study. (18)FDG-PET/CT imaging was performed, and standard uptake value (SUV) was calculated for each patient. SUV(max) was considered as the maximum value measured in the visualized lesions. Seven of the twelve cases exhibited uptake of (18)FFDG with an SUV(max) ranging from 1 to 8.1. Histopathologic diagnosis after surgery confirmed the diagnosis of IP in five cases; all these cases had an SUV(max) > 3. The five cases, which exhibited absence of (18)FDG uptake, had a histological diagnosis of absence of IP.


Subject(s)
Fluorodeoxyglucose F18/metabolism , Nose Neoplasms/diagnosis , Papilloma/diagnosis , Paranasal Sinuses/pathology , Adult , Aged , Female , Humans , Male , Middle Aged , Multimodal Imaging , Positron-Emission Tomography , Tomography, X-Ray Computed
4.
Radiol Med ; 117(1): 1-5, 2012 Feb.
Article in English, Italian | MEDLINE | ID: mdl-22020430

ABSTRACT

We review the current approach to using gadoliniumbased contrast agents taking into account data published in the literature and US Food and Drug Administration and European Medicines Evaluation Agency (EMEA) guidelines.


Subject(s)
Contrast Media/adverse effects , Gadolinium/adverse effects , Magnetic Resonance Imaging , Nephrogenic Fibrosing Dermopathy/chemically induced , Europe , Humans , Nephrogenic Fibrosing Dermopathy/prevention & control , Risk Factors , United States , United States Food and Drug Administration
5.
Q J Nucl Med Mol Imaging ; 55(4): 353-73, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21738112

ABSTRACT

Aim of our paper is to review the most important radio-compounds that can be successfully used to detect and/or characterize bone metastases. From a didactic point of view, we made a distinction between two main categories , the first allowing to individuate bone's reaction (osteotropic agents), the second trying to detect metastatic tumor cells (oncotropic agents). A wide description of the most diffuse Tc-99m diphosphonates , including analysis of uptake mechanisms and pharmacokinetics, is followed by a brief report on pathophysiological premises to the clinical use of F-18 fluoride and of specific (radioiodine, radiolabeled somatostatin or cathecolamine analogues) or non specific, as Tc-99m sestamibi, F-18 fluorodeoxhyglucose, F-18 choline, F-18 thymidine) oncotropic agents. At the end, the possibility to use diagnostic radiotracers to act both in recruiting patients with bone metastases undergoing radionuclide therapy and for their dosimetric evaluation is also discussed.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Diphosphonates/pharmacokinetics , Iodine Radioisotopes/pharmacokinetics , Organometallic Compounds , Organophosphorus Compounds , Technetium Compounds/pharmacokinetics , Bone Neoplasms/diagnosis , Bone Neoplasms/physiopathology , Bone and Bones/diagnostic imaging , Bone and Bones/physiopathology , Choline/analogs & derivatives , Choline/pharmacokinetics , Dihydroxyphenylalanine/analogs & derivatives , Diphosphonates/therapeutic use , Humans , Iodine Radioisotopes/therapeutic use , Organometallic Compounds/pharmacokinetics , Organometallic Compounds/therapeutic use , Organophosphorus Compounds/pharmacokinetics , Organophosphorus Compounds/therapeutic use , Radiography , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Technetium Compounds/therapeutic use , Technetium Tc 99m Sestamibi
6.
Minerva Endocrinol ; 36(1): 41-52, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21460786

ABSTRACT

The somatostatin receptor scintigraphy (SRS), using octreotide radiolabelled with 111In (octreoscan, OCTs), is a consolidated diagnostic procedure in patients with neuroendocrine tumors. A higher accuracy has been demonstrated with single photon emission computed tomography-CT, while a further improvement has been obtained with positron emission tomography (PET)-CT, using somatostatin analogues radiolabeled with 68Ga, significantly increasing the number of detected lesions. Although the well-known presence of an OCTs uptake in many benign diseases, when in an active phase, the application of SRS in these patients did not find any clinical relevance yet. In this paper we discuss two fields of endocrinological interest where SRS could play a clinical role. In patients with Graves exophtalmos, the capability to differentiate between active and non-active disease can be helpful in define prognosis and therapeutic strategies. In patients with endocrine paraneoplastic syndromes (PNS), SRS can help in finding the underlying neoplasm, contributing to its characterization as premise to a therapeutic choice. The possible role of a surgery guided by OCTs is also explained and suggested. The incremental value of PET-CT with Ga-68 peptides is hypothesized to reduce the number of unknown neoplastic lesions frequently present in patients with PNS.


Subject(s)
Neuroendocrine Tumors/diagnostic imaging , Paraneoplastic Endocrine Syndromes/diagnostic imaging , Positron-Emission Tomography , Radiopharmaceuticals , Somatostatin/analogs & derivatives , Cushing Syndrome/diagnostic imaging , Graves Disease/diagnostic imaging , Humans , Osteomalacia/diagnostic imaging , Positron-Emission Tomography/methods , Predictive Value of Tests , Sensitivity and Specificity , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed
7.
Radiol Med ; 116(1): 152-62, 2011 Feb.
Article in English, Italian | MEDLINE | ID: mdl-20852953

ABSTRACT

PURPOSE: This study evaluated the appropriateness and accuracy of 500 radiology requests and their matched reports in order to identify recurring errors in both areas. MATERIALS AND METHODS: A randomly chosen sample consisting of 167 computed tomography (CT), 166 ultrasonography (US) and 167 radiographic examinations were collected and analysed according to national referral guidelines and to the principles of justification and optimisation (Law no. 187/2000). RESULTS: We identified a high rate of inappropriate requests (27.6%) and requests lacking a clinical question (22%). There was good precision in the anamnestic data (80.6%) and in the formulation of the diagnostic question (76.8%). Almost all requests were handwritten, and 12.5% lacked the referring physician's stamp and/or signature. No report mentioned the clinical information received or the equipment used. The use of contrast medium was always reported. Conclusions were reported in 9.8% of these reports. When further investigation would have been necessary, the radiologist omitted to report this in 60% of cases. CONCLUSIONS: Some important weaknesses emerged, especially regarding requests for radiological examinations (22% lacked the clinical question, 27.6% were inappropriate), potentially limiting the effectiveness of the diagnostic process and leading to negative effects on the correct risk management process. There emerges a need for better collaboration between clinicians and radiologists.


Subject(s)
Referral and Consultation/statistics & numerical data , Tomography, X-Ray Computed/statistics & numerical data , Ultrasonography/statistics & numerical data , Contrast Media , Humans , Italy , Practice Guidelines as Topic
8.
Radiol Med ; 116(1): 1-14, 2011 Feb.
Article in English, Italian | MEDLINE | ID: mdl-20981503

ABSTRACT

UNLABELLED: This paper analyses off-label prescribing of the iodinated organic and magnetic resonance (MR) contrast media used in diagnostic imaging and evaluates the liability profiles and medicolegal issues associated with such use. The term off-label generally indicates the use of known drugs for which new scientific evidence suggests use in a manner and in clinical scenarios not explicitly addressed by the drug data sheet and is outside the indications for which the medication was approved. In addition, the term also indicates the use of drugs with a different route of administration and dosage from those indicated in the information leaflet. Intravascular contrast media used in diagnostic imaging are drugs in the complete sense of the term, even though they have unique characteristics which in many ways distinguish them from other pharmacological agents. The off-label use of contrast media in diagnostic imaging is a little-investigated field and most commonly, but not exclusively, applies to gadolinium-based contrast media used in MR angiography as well as cardiac and paediatric applications. In particular, the off-label use of contrast media mostly concerns deviations from the recommended dose. As contrast media are to all effects pharmaceutical agents, their off-label use can be considered admissible within the limitations laid down by the Italian law in force (Article 3 of Law 94/98) and its interpretation, i.e. the following criteria must be present: the lack of a valid diagnostic alternative; written informed consent by the patient; the presence of scientific publications validated at the international level; assumption of responsibility by the radiologist. CONCLUSIONS: The use of contrast media in modern image-guided medicine is essential. In cases in which the information contained in the information leaflet is modified and updated in any way whatsoever (indications, dosage, at others), specifically if restrictions are introduced in accordance with the law in force, the pharmaceutical industry must provide formal and timely notification to radiologists. On their part as prescribers and users of contrast media, radiologists must remain up to date regarding any changes in indications, dosage and route of administration. Lastly, we propose that the radiology report includes not only the type but also the dose of contrast medium used.


Subject(s)
Contrast Media/pharmacology , Magnetic Resonance Imaging , Off-Label Use , Contrast Media/administration & dosage , Contrast Media/adverse effects , Humans , Iodine , Italy , Off-Label Use/economics , Off-Label Use/ethics , Off-Label Use/legislation & jurisprudence
10.
Clin Nephrol ; 70(6): 514-7, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19049709

ABSTRACT

Nephrogenic systemic fibrosis (NSF) is a systemic disease, recently described in patients with advanced chronic kidney disease (CKD), characterized by progressive scleromyxedema-like fibrotic involvement mainly of the skin. We describe the case of a 66-year-old woman on chronic hemodialysis for end-stage renal failure, also affected by hypothyroidism, secondary hyperparathyroidism and occluding arteriopathy, for which she underwent a contrast-enhanced magnetic resonance angiography of the lower limbs in February 2007. One month later, she began complaining of progressive, painful distal lower limb stiffness, which subsequently spread to all four limbs and to the whole trunk. A deep-skin biopsy, taken from an affected area, showed gadolinium deposits. The case reported is, to best of our knowledge, the first Italian case of NSF. This diagnosis should be considered with care in CKD patients with a recent exposure to a gadolinium-based contrast agent, complaining of limb stiffness, especially in the presence of risk factors.


Subject(s)
Contrast Media/administration & dosage , Gadolinium DTPA , Kidney Failure, Chronic/complications , Magnetic Resonance Angiography/methods , Nephrogenic Fibrosing Dermopathy/diagnosis , Aged , Contrast Media/pharmacokinetics , Diagnosis, Differential , Female , Follow-Up Studies , Gadolinium DTPA/pharmacokinetics , Humans , Italy , Kidney Failure, Chronic/therapy , Nephrogenic Fibrosing Dermopathy/etiology , Nephrogenic Fibrosing Dermopathy/metabolism , Renal Dialysis/methods , Skin/metabolism , Skin/pathology
11.
Radiol Med ; 113(8): 1157-70, 2008 Dec.
Article in English, Italian | MEDLINE | ID: mdl-18958408

ABSTRACT

PURPOSE: The aim of the study was to assess the reliability of whole-body magnetic resonance imaging (WB-MRI) in detecting skeletal metastasis and to compare the results with those of bone scintigraphy (BS). MATERIALS AND METHODS: Thirty-three patients (21 women, 12 men, median age 58 years, range 27-78) were enrolled. Histological proof of malignancy was obtained in all cases. The primary tumour was unknown in 1 patient. BS and WB-MRI were performed as staging procedures in 15 patients, during the follow-up in 6 and to investigate pain in 9 and neurological symptoms in 3. Bone metastases were recorded for 8 different skeletal segments (ribs, skull, cervicothoracic spine, lumbosacral spine, clavicle-scapula-sternum, pelvis, upper extremities and lower extremities) in all patients, for a total of 264 examined areas. RESULTS: Bone metastases were detected in 18 patients (55%). In 15/33 patients, WB-MRI and BS were concordantly negative. BS revealed focal metastatic uptake in 72%, whereas WB-MRI was positive in 89%. Results differed in seven patients. WB-MRI was positive but BS was negative in five cases. Two patients with negative WB-MRI had focal and intense uptake in the ribs on BS. Out of 264 examined areas, bone metastases were detected in 34 (13%). WB-MRI revealed tumour spread in 26/34 areas (76%) and BS in 21/34 areas only (62%). CONCLUSIONS: WB-MRI is a reliable method for screening patients with suspected skeletal metastases, although BS still remains a useful tool. WB-MRI is also advantageous because it reveals extraskeletal and soft tissue metastases.


Subject(s)
Bone Neoplasms/diagnosis , Bone Neoplasms/secondary , Magnetic Resonance Imaging , Adult , Aged , Bone Neoplasms/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Radionuclide Imaging , Reproducibility of Results
14.
Prostate Cancer Prostatic Dis ; 11(2): 121-8, 2008.
Article in English | MEDLINE | ID: mdl-18180806

ABSTRACT

The patient population with a rising prostate specific antigen (PSA) post-therapy with no evidence of disease on standard imaging studies currently represents the second largest group of prostate cancer patients. Little information is still available regarding the specificity and sensitivity of positron emission tomography (PET) tracers in the assessment of early biochemical recurrence. Ideally, PET imaging would allow one to accurately discriminate between local vs nodal vs distant relapse, thus enabling appropriate selection of patients for salvage local therapy. The vast majority of studies show a relatively poor yield of positive scans with PSA values < 4 ng ml(-1). So far, no tracer has been shown to be able to detect local recurrence within the clinically useful 1 ng ml(-1) PSA threshold, clearly limiting the use of PET imaging in the post-surgical setting. Preliminary evidence, however, suggests that 11C-choline PET may be useful in selecting out patients with early biochemical relapse (PSA < 2 ng ml(-1)) who have pelvic nodal oligometastasis potentially amenable to local treatment. The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm. Well-conducted studies comparing the merits of different tracers are needed.


Subject(s)
Adenocarcinoma/diagnostic imaging , Adenocarcinoma/secondary , Lymphatic Metastasis/diagnostic imaging , Neoplasm Recurrence, Local/diagnostic imaging , Positron-Emission Tomography , Prostatic Neoplasms/diagnostic imaging , Adenocarcinoma/blood , Adenocarcinoma/pathology , Carbon Radioisotopes , Choline , Clinical Trials as Topic , Humans , Male , Patient Selection , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology , Radiopharmaceuticals , Sensitivity and Specificity
15.
Radiol Med ; 112(5): 703-21, 2007 Aug.
Article in English, Italian | MEDLINE | ID: mdl-17653627

ABSTRACT

Magnetic resonance imaging (MRI) has opened new possibilities to current diagnostic radiology in the evaluation of bone marrow. Compared with other imaging modalities, MRI is the only technique able to directly visualise bone marrow with its different components of red and yellow marrow. Other advantages of MRI are high-contrast resolution and multiplanar view, as well as extensive coverage of the skeleton with whole-body MRI (WBMRI). However, specificity of signal alterations of bone marrow is low. Therefore, MRI findings need to be integrated with clinical and laboratory findings as well as with haematological and oncological evaluation. MRI provides information that effectively aids diagnosis, staging and follow-up of various bone marrow disorders. There is increasing interest in the capabilities of MRI in the evaluation of bone marrow, in particular of haematological malignancies. According to some authors much work remains to be done to improve sensitivity and specificity of MRI in order to define the real clinical value of this imaging modality in the multidisciplinary management of patients with a haematological malignancy. This article presents recent developments and perspectives in the use of MRI in oncohaematological diseases.


Subject(s)
Bone Marrow Diseases/diagnosis , Hematologic Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Bone Marrow Diseases/therapy , Contrast Media , Diagnosis, Differential , Hematologic Neoplasms/therapy , Humans , Sensitivity and Specificity
18.
Minerva Cardioangiol ; 52(1): 9-17, 2004 Feb.
Article in English, Italian | MEDLINE | ID: mdl-14765033

ABSTRACT

AIM: The aim of this study is to evaluate the accuracy of multidetector row CT angiography (MDCTA) of the abdominal aorta and lower extremities arteries in patients with peripheral arterial occlusive disease who did not receive any prior treatment whether interventional or surgical. METHODS: Twenty-two patients with peripheral vascular occlusive disease (16 male, 6 female, age range 44-85 years) underwent MDCTA of the abdominal aorta and lower extremities. Digital subtraction angiography (DSA) of the same districts was performed within 3 months. Images were blindly interpreted by 2 interventional radiologists and compared with the results of digital subtraction angiography. RESULTS: Sensitivity and specificity of MDCTA were 92% and 94%, respectively, with positive and negative predictive values of 93% and 95%. Overall diagnostic accuracy was 93%. Normal arterial segments and 100% occlusions were correctly identified in all cases by MDCTA. Moderately stenotic segments interpretation in the calves appeared to be more controversial, but no statistical difference in accuracy in this district was noted with respect to accuracy in more proximal arteries. CONCLUSION: MDCTA of the abdominal aorta and lower extremities is a feasible, accurate imaging modality in clinical practice when compared to DSA.


Subject(s)
Angiography, Digital Subtraction , Angiography , Aorta, Abdominal/diagnostic imaging , Arterial Occlusive Diseases/diagnostic imaging , Leg/blood supply , Peripheral Vascular Diseases/diagnostic imaging , Tomography, Spiral Computed , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity , Tomography, Spiral Computed/methods
19.
Radiol Med ; 102(4): 226-32, 2001 Oct.
Article in Italian | MEDLINE | ID: mdl-11740449

ABSTRACT

PURPOSE: To reaffirm the role of MRI in the assessment of the M#159;llerian duct anomalies (MDAs). MATERIAL AND METHODS: Between November 1997 and April 2001, 22 patients, age range 18-40 years (mean 29 years) were investigated with MRI and US. The MRI study was performed with a 0,5 Tesla imager (Vectra, GE Medical System) with body-coil; neither oral nor intravenous contrast was used. We obtained SE T1-weighted, fast STIR with fat suppression and FSE T2-weighted sequences. Sagittal, paracoronal and paraxial images were acquired. The paraxial images were obtained to produce true coronal images of the uterus. In evaluating MDAs, imaging the uterus in its true coronal plane is essential to assess the external fundal contour. US examination was performed with an HDI 3000, ATL, using the trans-vaginal approach. The MDAs were subdivided according to the Buttram and Gibbons classification. RESULTS: There were 22 cases of laparoscopic and hysteroscopic proved anomalies; MRI allowed correct diagnosis of 21 uterine anomalies (accuracy, 95%) whereas U.S. was correct in 20 of 22 cases (accuracy, 92%). The MRI was excellent in depicting the uterine morphology in one case of unicornuate uterus with rudimentary horn non-comunicating with the main cavity and distended by hematometra and associated hematosalpinx. Further-more evaluating composition, thickness and extension of the uterine septum and aspect of the fundal contour, MRI allowed to differentiate definitively between bicornuate uterus and septate uterus. This is a very important distinction to do because it significantly affects patient treatment: a septate uterus requires hysteroscopic septectomy, while a bicornuate uterus does not requires surgical treatment. CONCLUSIONS: Given its characteristics, MRI is a very accurate imaging modality in uterine evaluation and contributes significantly to treatment planning. Although ultrasonography remains the modality of choice for the initial study of patients who are suspected of having a MDAs, we propose, in accordance with many authors in the literature, to reserve MRI imaging for patients with a technically inadequate or indeterminate ultrasound examination.


Subject(s)
Magnetic Resonance Imaging , Mullerian Ducts/abnormalities , Mullerian Ducts/pathology , Adolescent , Adult , Female , Humans
20.
Atherosclerosis ; 158(1): 53-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11500174

ABSTRACT

Strain gauge plethysmography and brachial artery ultrasound are widely used to study endothelial function. No data on correlation between these two procedures are reported. The present study compared these two methods and investigated the correlation between vasodilation and brachial wall shear stress. In six healthy subjects and ten patients with hypertension or obesity, strain gauge plethysmography was performed in resting conditions and after infusion of 7.5,15 and 30 microg/min of acetylcholine, and brachial artery ultrasound in resting conditions and after 5 min hand ischemia. Wall shear stress was calculated as: blood viscosity x blood velocity/internal diameter. Forearm blood flow following acetylcholine infusion increased more in healthy subjects than in patients with hypertension or obesity. In addition, brachial artery dilated more in the former group. Change in brachial artery diameter correlated with change in forearm blood flow, calculated as area under the curve of acetylcholine infusion (r=0.739, P<0.001). Wall shear stress was higher in healthy subjects (67.8+/-20.0 dynes/cm(2)) than in patients with either hypertension or obesity (39.2+/-16.7, P<0.001), and correlated with variations of diameter (r=0.796, P<0.0002), and marginally of blood flow (r=0.516, P<0.05). The present findings demonstrate that there is a high correlation between endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Wall shear stress correlates with brachial artery diameter change following hand ischemia, and marginally with blood flow change following acetylcholine infusion.


Subject(s)
Brachial Artery/diagnostic imaging , Endothelium, Vascular/physiology , Plethysmography , Ultrasonography, Doppler , Acetylcholine/pharmacology , Adult , Biomechanical Phenomena , Blood Flow Velocity , Blood Viscosity , Endothelium, Vascular/physiopathology , Forearm/blood supply , Humans , Hypertension/physiopathology , Male , Middle Aged , Obesity/physiopathology , Vasodilation/drug effects , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...